Try Fund Library Premium
For Free with a 30 day trial!
Sector Equity
Click for more information on Fundata’s ESG Grade
Click for more information on Fundata’s ESG Grade.
|
NAVPS (04-02-2025) |
$6.45 |
|---|---|
| Change |
$0.21
(3.36%)
|
As at February 28, 2025
As at February 28, 2025
As at December 31, 2024
Loading...
Inception Return (November 04, 2022): -9.57%
| Row Heading | Return | Annualized Return | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 Mth | 3 Mth | 6 Mth | YTD | 1 Yr | 2 Yr | 3 Yr | 4 Yr | 5 Yr | 6 Yr | 7 Yr | 8 Yr | 9 Yr | 10 Yr | |
| Fund | -8.69% | -2.11% | -0.35% | 4.85% | -17.12% | -8.44% | - | - | - | - | - | - | - | - |
| Benchmark | -0.40% | -0.31% | 10.31% | 3.06% | 22.45% | 15.63% | 9.72% | 12.23% | 12.73% | 11.38% | 10.72% | 9.76% | 11.18% | 8.50% |
| Category Average | -2.93% | 0.20% | 5.42% | 1.44% | 12.52% | 20.92% | 9.16% | 6.63% | 12.64% | 11.56% | 11.01% | 11.76% | 12.30% | 10.47% |
| Category Rank | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Quartile Ranking | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Return % | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Jan | Feb |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fund | -8.88% | -17.74% | 4.36% | -3.64% | 14.97% | -4.02% | -2.56% | -6.81% | 12.11% | -6.65% | 14.83% | -8.69% |
| Benchmark | 4.14% | -1.82% | 2.77% | -1.42% | 5.87% | 1.22% | 3.15% | 0.85% | 6.37% | -3.27% | 3.48% | -0.40% |
17.40% (November 2023)
-17.74% (April 2024)
| Return % | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Fund | - | - | - | - | - | - | - | - | 11.84% | -22.41% |
| Benchmark | -8.32% | 21.08% | 9.10% | -8.89% | 22.88% | 5.60% | 25.09% | -5.84% | 11.75% | 21.65% |
| Category Average | 16.21% | -0.43% | 20.39% | 1.55% | 22.37% | 29.99% | 15.34% | -25.24% | 26.53% | 20.41% |
| Quartile Ranking | - | - | - | - | - | - | - | - | - | - |
| Category Rank | - | - | - | - | - | - | - | - | - | - |
11.84% (2023)
-22.41% (2024)
| Name | Percent |
|---|---|
| US Equity | 89.12 |
| International Equity | 8.11 |
| Cash and Equivalents | 2.57 |
| Canadian Equity | 0.20 |
| Name | Percent |
|---|---|
| Healthcare | 84.34 |
| Technology | 5.20 |
| Cash and Cash Equivalent | 2.57 |
| Industrial Goods | 0.53 |
| Other | 7.36 |
| Name | Percent |
|---|---|
| North America | 91.89 |
| Europe | 8.11 |
| Name | Percent |
|---|---|
| Recursion Pharmaceuticals Inc Cl A | 7.96 |
| CRISPR Therapeutics AG | 7.53 |
| Twist Bioscience Corp | 7.41 |
| TEMPUS AI INC | 7.36 |
| Adaptive Biotechnologies Corp | 5.30 |
| Natera Inc | 5.25 |
| Guardant Health Inc | 4.93 |
| CareDx Inc | 4.73 |
| Schrodinger Inc | 4.23 |
| Beam Therapeutics Inc | 4.15 |
| Standard Deviation | - | - | - |
|---|---|---|---|
| Beta | - | - | - |
| Alpha | - | - | - |
| Rsquared | - | - | - |
| Sharpe | - | - | - |
| Sortino | - | - | - |
| Treynor | - | - | - |
| Tax Efficiency | - | - | - |
| Volatility | - | - | - |
| Key Ratio | 1 Yr | 3 Yr | 5 Yr | 10 Yr |
|---|---|---|---|---|
| Standard Deviation | 36.06% | - | - | - |
| Beta | 2.49% | - | - | - |
| Alpha | -0.65% | - | - | - |
| Rsquared | 0.54% | - | - | - |
| Sharpe | -0.47% | - | - | - |
| Sortino | -0.63% | - | - | - |
| Treynor | -0.07% | - | - | - |
| Tax Efficiency | - | - | - | - |
The E, S, and G scores are averaged for each security in the portfolio, to arrive at an ESG score for each security. We take the portfolio weighted average of the ESG scores for each fund and rank them against their peers to arrive at the Fundata ESG Score from 0-100.
Three scores under the Environment bucket are averaged to yield the Fundata Environment Score for each fund from 0-100: (1) Pollution Prevention, (2) Environmental Transparency, (3) Resource Efficiency.
Six scores under the Social bucket are averaged to yield the Fundata Social Score for each fund from 0-100. (1) Compensation and Satisfaction, (2) Diversity and Rights, (3) Education and Work Conditions, (4) Community and Charity, (5) Human Rights, (6) Sustainability Integration.
Three scores under the governance bucket are averaged to yield the Fundata Governance Score for each fund from 0-100: (1) Board Effectiveness, (2) Management Ethics, (3) Disclosure and Accountability.
Powered by OWL Analytics. For more information, please contact Fundata Canada.
| Start Date | November 04, 2022 |
|---|---|
| Instrument Type | Mutual Fund |
| Share Class | Commission Based Advice |
| Legal Status | Trust |
| Sales Status | Open |
| Currency | CAD |
| Distribution Frequency | Annual |
| Assets ($mil) | $7 |
| FundServ Code | Load Code | Sales Status |
|---|---|---|
| BMO70264 |
This fund’s objective is to provide long-term capital growth by investing primarily in equity securities of companies involved in disruptive genomic innovation from around the world.
These are the strategies the portfolio manager uses to try to achieve the fund’s objectives: invests primarily in global equity securities of companies across various sectors that are focused on and are expected to substantially benefit from extending and enhancing the quality of human and other life by incorporating technological and scientific developments and advancements in genomics into their business.
| Portfolio Manager |
Ark Investment Management LLC
|
|---|---|
| Sub-Advisor |
- |
| Fund Manager |
BMO Investments Inc. |
|---|---|
| Custodian |
- |
| Registrar |
- |
| Distributor |
- |
| RSP Eligible | Yes |
|---|---|
| PAC Allowed | No |
| PAC Initial Investment | - |
| PAC Subsequent | - |
| SWP Allowed | No |
| SWP Min Balance | - |
| SWP Min Withdrawal | - |
| MER | 1.98% |
|---|---|
| Management Fee | 1.75% |
| Load | No Load |
| FE Max | - |
| DSC Max | - |
| Trailer Fee Max (FE) | - |
| Trailer Fee Max (DSC) | - |
| Trailer Fee Max (NL) | 1.00% |
| Trailer Fee Max (LL) | - |
Try Fund Library Premium
For Free with a 30 day trial!
Fund Library
